Patents Assigned to Glaxco Wellcome Inc.
  • Ondansetron freeze-dried dosage form compositions for oral administration
    Patent number: 6063802
    Abstract: The invention relates to a freeze-dried dosage form for oral administration capable of being rapidly disintegrated in the mouth comprising ondansetron in the form of its free base or a pharmaceutically acceptable solvate thereof and one or more pharmaceutically acceptable excipients. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine (5HT) at 5HT.sub.3 receptors are also described.
    Type: Grant
    Filed: January 28, 1999
    Date of Patent: May 16, 2000
    Assignee: Glaxco Wellcome Inc.
    Inventor: Ian Keith Winterborn